Prevalence and impact of diabetes and prediabetes on presentation and complications of primary hyperaldosteronism at diagnosis

Table 1 Demographic variables, glycaemic and hypertensive parameters (mean ± SD)

	No diabetes (n = 30)	Prediabetes (n = 19)	T2DM (n = 29)	P value
Age (yr)	52.53 ± 13.71	55.89 ± 15.1	56 ± 10.13	NS
HbA1c (%)	5.277 ± 0.25	5.926 ± 0.24	7.463 ± 0.59	< 0.0001
FPG (mg/dL)	87.9 ± 6.46	105.4 ± 9.02	130.6 ± 21.12	< 0.0001
PPPG (mg/dL)	122.7 ± 9.75	154.9 ± 14	196.7 ± 38.03	< 0.0001
HTN duration (yr)	11.27 ± 7.18	14.05 ± 8.35	14.83 ± 7.44	NS
SBP (mmHg)	164.9 ± 10.93	165.6 ± 15.3	165 ± 15.01	NS
DBP (mmHg)	95.37 ± 14.88	94.95 ± 7.41	98 ± 17.36	NS
BMI	23.6 ± 1.3	24.4 ± 1.4	25.2 ± 3.6	0.0479

NS: Non-significant, P ≥ 0.05; P < 0.05: Statistically significant; T2DM: Type 2 diabetes mellitus; HbA1c: Glycated haemoglobin; FPG: Fasting plasma glucose; PPPG: Post prandial plasma glucose; HTN: Hypertension; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BMI: Body mass index.